ATE294236T1 - Promotor der tie rezeptor protein kinase - Google Patents

Promotor der tie rezeptor protein kinase

Info

Publication number
ATE294236T1
ATE294236T1 AT95931236T AT95931236T ATE294236T1 AT E294236 T1 ATE294236 T1 AT E294236T1 AT 95931236 T AT95931236 T AT 95931236T AT 95931236 T AT95931236 T AT 95931236T AT E294236 T1 ATE294236 T1 AT E294236T1
Authority
AT
Austria
Prior art keywords
promoter
protein kinase
receptor protein
tie receptor
tie
Prior art date
Application number
AT95931236T
Other languages
English (en)
Inventor
Kari Alitalo
Original Assignee
Licentia Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Licentia Ltd filed Critical Licentia Ltd
Application granted granted Critical
Publication of ATE294236T1 publication Critical patent/ATE294236T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Spectrometry And Color Measurement (AREA)
  • Investigating Materials By The Use Of Optical Means Adapted For Particular Applications (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Sorting Of Articles (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Length Measuring Devices By Optical Means (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT95931236T 1994-09-22 1995-09-22 Promotor der tie rezeptor protein kinase ATE294236T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31071794A 1994-09-22 1994-09-22
PCT/FI1995/000520 WO1996009381A1 (en) 1994-09-22 1995-09-22 Promoter for the receptor tyrosine kinase, tie

Publications (1)

Publication Number Publication Date
ATE294236T1 true ATE294236T1 (de) 2005-05-15

Family

ID=23203808

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95931236T ATE294236T1 (de) 1994-09-22 1995-09-22 Promotor der tie rezeptor protein kinase

Country Status (8)

Country Link
US (1) US5877020A (de)
EP (1) EP0783572B1 (de)
JP (1) JPH10506011A (de)
AT (1) ATE294236T1 (de)
AU (1) AU701568B2 (de)
DE (1) DE69534180T2 (de)
NO (1) NO971341L (de)
WO (1) WO1996009381A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2756570B1 (fr) * 1996-12-03 2002-09-27 Commissariat Energie Atomique Promoteur de la ve-cadherine et ses utilisations
US5972338A (en) 1997-09-19 1999-10-26 Genentech, Inc. Tie ligands homologues
US6350450B1 (en) 1997-09-19 2002-02-26 Genentech, Inc. TIE ligand homologue antibody
US6057435A (en) 1997-09-19 2000-05-02 Genentech, Inc. Tie ligand homologues
US6348350B1 (en) 1997-09-19 2002-02-19 Genentech, Inc. Ligand homologues
US6030831A (en) * 1997-09-19 2000-02-29 Genetech, Inc. Tie ligand homologues
US6130207A (en) * 1997-11-05 2000-10-10 South Alabama Medical Science Foundation Cell-specific molecule and method for importing DNA into a nucleus
WO2001072339A2 (en) * 2000-03-30 2001-10-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method of treatment of conditions involving obstruction of blood flow
JP2004517080A (ja) * 2000-11-29 2004-06-10 グラクソ グループ リミテッド Ｔｉｅ−２および／またはｖｅｇｆｒ−２の阻害剤として有用なベンゾイミダゾール誘導体
US20090181092A1 (en) * 2004-07-16 2009-07-16 Spinal Restoration, Inc. Methods for Treating Joints and Discs with a Carrier Matrix and Cells
GB0423554D0 (en) * 2004-10-22 2004-11-24 Cancer Rec Tech Ltd Therapeutic compounds
GB0428082D0 (en) * 2004-12-22 2005-01-26 Welcome Trust The Ltd Therapeutic compounds
US7951819B2 (en) 2006-04-26 2011-05-31 Cancer Research Technology Limited Imidazo[4, 5-B]pyridin-2-one and oxazolo[4, 5-B] pyridin-2-one compounds and analogs thereof as cancer therapeutic compounds
JP2010540534A (ja) * 2007-09-28 2010-12-24 イントレキソン コーポレーション 生体治療分子の発現のための治療遺伝子スイッチ構築物およびバイオリアクター、ならびにその使用
CN101945869B (zh) 2007-12-19 2014-06-18 癌症研究技术有限公司 吡啶并[2,3-b]吡嗪-8-取代化合物及其用途
GB0807609D0 (en) * 2008-04-25 2008-06-04 Cancer Rec Tech Ltd Therapeutic compounds and their use
WO2011092469A1 (en) 2010-02-01 2011-08-04 Cancer Research Technology Limited 1-(5-tert-butyl-2-phenyl-2h-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy
EP2956159A1 (de) 2013-02-14 2015-12-23 UCL Business Plc. Mittel zur induzierung von lymphangiogenese zur verwendung bei der behandlung von zystennierenerkrankungen
GB201320729D0 (en) 2013-11-25 2014-01-08 Cancer Rec Tech Ltd Therapeutic compounds and their use
GB201320732D0 (en) 2013-11-25 2014-01-08 Cancer Rec Tech Ltd Methods of chemical synthesis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3353293A (en) * 1992-01-09 1993-08-03 Helsinki University Holding, Ltd. Tie, a novel endothelial cell receptor tyrosine kinase
US5466596A (en) * 1992-08-25 1995-11-14 Mount Sinai Hospital Corporation Tissue specific transcriptional regulatory element

Also Published As

Publication number Publication date
DE69534180T2 (de) 2006-03-02
AU701568B2 (en) 1999-02-04
NO971341L (no) 1997-05-14
NO971341D0 (no) 1997-03-21
DE69534180D1 (de) 2005-06-02
WO1996009381A1 (en) 1996-03-28
AU3474895A (en) 1996-04-09
US5877020A (en) 1999-03-02
EP0783572A1 (de) 1997-07-16
JPH10506011A (ja) 1998-06-16
EP0783572B1 (de) 2005-04-27

Similar Documents

Publication Publication Date Title
ATE294236T1 (de) Promotor der tie rezeptor protein kinase
ATE309360T1 (de) Vaskularer endothelialer wachstumsfaktor 2
TR199901172T2 (xx) Yeni ikame edilmi� pirazol t�revleri.
DE69837996D1 (de) Tumornekrosefaktor-rezeptoren 6 alpha& 6 beta
DE68929043D1 (de) Für androgen-rezeptor-protein kodierende dna
DE69836131D1 (de) Neue menschliche delta3-zusammensetzung und deren therapeutische und diagnostische verwendungen
DE69726741D1 (de) Verwendungen von angiogenischer factor vegf145 in der behandlung von kardiovaskulaeren krankheiten
DK0464533T3 (da) Fusionsproteiner med immunglobulindele, deres fremstilling og anvendelse
DK0960127T3 (da) Isoleret dimert fibroblastaktiverende protein-alfa og anvendelser deraf
ATE354638T1 (de) Menschlicher gewebsinhibitor von metalloproteinase-4
DK1007537T3 (da) Receptor-protein med betegnelsen 2F1
ATE396205T1 (de) Die verwendung von peptiden von il-2 und peptid- derivaten als therapeutische wirkstoffe
IS2819B (is) Viðloðunarsameindir í æðum og mótun á starfsemi@þeirra
EA200100264A1 (ru) Ангиоцидин: адгезионный рецептор опухолей клетки, специфический для cys-ser-val-thr-cys-gly
BR0009170A (pt) ácidos nucléicos akt, polipeptìdeos e uso dos mesmos
NO982181L (no) Type IX collagen og chimerer
BR9908096A (pt) Proteìna 3 da zona pelúcida humana (hzp3), ativa, recombinante
DK0939769T3 (da) Vertebrat-Smoothened-proteiner
NO961423D0 (no) Oligopeptider avledet fra C-reaktive proteinfragmenter
IT1299201B1 (it) Fibroblasti modificati geneticamente e loro uso
BR0012704A (pt) Anticorpos antitumor, proteìnas e usos dos mesmos
DE59708511D1 (de) Verwendung von 7-(1-aminomethyl-2-oxa-7-aza-bicyclo 3.3.0]oct-7-yl)-chinoloncarbonsäure- und -naphthyridoncarbonsäure-derivaten zur therapie von helicobacter-pylori-infektionen und den damit assoziierten gastroduodenalen erkrankungen
DE69712182D1 (de) Peptide und ihre verwendung in der therapie von krankheiten des zöliakie-formenkreises
IS5231A (is) Vefjaþáttur sem hefur áhrif á blóðæðarmyndun
CA2200846A1 (en) Promoter for the receptor tyrosine kinase, tie

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0783572

Country of ref document: EP

REN Ceased due to non-payment of the annual fee